Nuocheng Jianhua and kangnoah deepen strategic cooperation and develop first in class macromolecular innovative drugs

Nuoyi Mayer completed a round of 100 million yuan a + + financing and deeply laid out multiple implantable medical device product pipelines

Kangyuan obtained tens of millions of yuan of round a financing for a long time and accelerated the application of jy108 dual anti drug ind

Microchip diabetes mellitus new drug glipizide sodium approved in China

New drugs will be on the shelves in three days at the fastest, and Ali health pharmacy starts the "new drug launch support plan"

Yiyi biological submitted ryzneuta to the European drug administration ™ Listing application accepted

After the layout of gene therapy track, Takeda reached a cooperation with selecta for more than US $1.1 billion

AstraZeneca acquires Caelum Biosciences overweight rare diseases business

Randomized trials show that whole genome sequencing is helpful to improve the nursing of critically ill infants in different situations

Triarm therapeutics completed a round of financing of US $60 million

Boehringer Ingelheim joins hands with Meixin health and Yuanxin technology to create an ecosystem for the management of the whole course of patients

Zhongkang technology and Huawei cloud strategic cooperation to accelerate the digital intelligence process of the pharmaceutical and health industry

The new Kangtaike is rejuvenated and loves to be fully opened

Puri benchmark obtained 150 million yuan of round B financing to promote the research and development of new drugs driven by multi omics data mining

Synsense technology, a brain chip company, completed nearly 200 million yuan of pre-B financing

Icosai biology completed round B financing of more than RMB 100 million and made great efforts to build a Chinese core for cell culture